Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and S... von Papp, Kim, MD, PhD, Reich, Kristian, MD, PhD, Leonardi, Craig L., MD, Kircik, Leon, MD, Chimenti, Sergio, MD, Langley, Richard G.B., MD, Hu, ChiaChi, EdM, MS, Stevens, Randall M., MD, Day, Robert M., PhD, Gordon, Kenneth B., MD, Korman, Neil J., MD, PhD, Griffiths, Christopher E.M., MD, FMedSci

Volltext

Efficacy of apremilast in the treatment of moderate to severe psoriasis: a randomised controlled trial von Papp, Kim, Dr, Cather, Jennifer C, MD, Rosoph, Les, MD, Sofen, Howard, MD, Langley, Richard G, MD, Matheson, Robert T, MD, Hu, ChiaChi, EdM, Day, Robert M, PhD

Volltext

Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor von Kavanaugh, Arthur, Mease, Philip J, Gomez-Reino, Juan J, Adebajo, Adewale O, Wollenhaupt, Jürgen, Gladman, Dafna D, Lespessailles, Eric, Hall, Stephen, Hochfeld, Marla, Hu, ChiaChi, Hough, Douglas, Stevens, Randall M, Schett, Georg

Volltext

Oral apremilast in the treatment of active psoriatic arthritis: Results of a multicenter, randomized, double-blind, placebo-controlled study von Schett, Georg, Wollenhaupt, Jurgen, Papp, Kim, Joos, Rik, Rodrigues, Jude F., Vessey, Adele R., Hu, ChiaChi, Stevens, Randall, de Vlam, Kurt L.

Volltext

Improvements in patient-reported outcomes with apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of moderate to severe psoriasis: results from a phase IIb randomi... von Strand, Vibeke, Fiorentino, David, Hu, ChiaChi, Day, Robert M, Stevens, Randall M, Papp, Kim A

Volltext

214. Efficacy of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, on Physical Function and Pain in Patients with Psoriatic Arthritis and Current Skin Involvement: Results of Pala... von Edwards, Christopher J., Blanco, Francisco J., Crowley, Jeffrey, Hu, ChiaChi, Stevens, Randall M., Birbara, Charles A.

Volltext

212. Long-Term 52-Week Results of Palace 3, A Phase 3, Randomized, Controlled Trial of Apremilast, An Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis and C... von Edwards, Christopher J., Blanco, Francisco J., Crowley, Jeffrey, Hu, ChiaChi, Stevens, Randall M., Birbara, Charles A.

Volltext

O03Apremilast, an Oral Phosphodiesterase-4 Inhibitor, is Associated with Long-Term (104-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Pooled... von Gladman, Dafna D, Kavanaugh, Arthur, Adebajo, Adewale O, Gomez-Reino, Juan J, Wollenhaupt, Juergen, Cutolo, Maurizio, Schett, Georg, Lespessailles, Eric, McIlraith, Melissa, Hu, ChiaChi, Edwards, Christopher J, Birbara, Charles A, Mease, Philip J

Volltext

217. Long-Term 52-Week Results of Palace 1, A Phase 3, Randomized, Controlled Trial of Apremilast, an Oral Phosphodiesterase Inhibitor, In atients with Psoriatic Arthritis von Adebajo, Adewale O., Kavanaugh, Arthur, Mease, Philip J., Wollenhaupt, Jürgen, Hu, ChiaChi, Shah, Kamal, Stevens, Randall M., Gomez-Reino, Juan J.

Volltext

Oral Apremilast in the Treatment of Active Psoriatic Arthritis: Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Study von SCHETT, Georg, WOLLENHAUPT, Jurgen, PAPP, Kim, JOOS, Rik, RODRIGUES, Jude F, VESSEY, Adele R, HU, Chiachi, STEVENS, Randall, DE VLAM, Kurt L

Volltext

Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor von Kavanaugh, Arthur

Volltext bestellen

Opportunity for HiAP through a Healthy Cities initiative in Taiwan: a multiple streams analysis von Lee, Chiachi Bonnie, Huang, Nuan-Ching, Kung, Shiann-Far, Hu, Susan C

Volltext

Gate insulation layer with improved etching angle and manufacturing method thereof von HUANG, CHUNCHIEH, CHEN, WEITING, HU, YOUYUAN, HUANG, CHIACHI

Volltext bestellen